Skip to main content
TipRanks
Go Ultimate75% OFF

Daré Bioscience (DARE) Stock Statistics & Valuation Metrics

1,904 Followers

Total Valuation

Daré Bioscience has a market cap or net worth of $12.93M. The enterprise value is $25.56M.

Market Cap
$12.93M
Enterprise Value
$25.56M

Share Statistics

Daré Bioscience has 19,669,083 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
19,669,083
Owned by Insiders
5.50%
Owned by Institutions
7.84%

Financial Efficiency

Daré Bioscience’s return on equity (ROE) is -4.71 and return on invested capital (ROIC) is -124.50%.

Return on Equity (ROE)
-4.71
Return on Assets (ROA)
-0.41
Return on Invested Capital (ROIC)
-124.50%
Return on Capital Employed (ROCE)
-1.54
Revenue Per Employee
44.79K
Profits Per Employee
-582.58K
Employee Count
23
Asset Turnover
0.03
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Daré Bioscience is -0.77. Daré Bioscience’s PEG ratio is -0.01.

PE Ratio
-0.77
PS Ratio
6.69
PB Ratio
-16.22
Price to FCF
-0.78
Price to Operating Cash Flow
-0.80
PEG Ratio
-0.01

Income Statement

In the last 12 months, Daré Bioscience had revenue of 1.03M and earned -13.40M in profits. Earnings per share was -1.20.

Revenue
1.03M
Gross Profit
-1.42M
Operating Income
-13.55M
Pretax Income
-13.40M
Net Income
-13.40M
EBITDA
-10.43M
Earnings Per Share (EPS)
-1.20

Cash Flow

In the last 12 months, operating cash flow was -11.29M and capital expenditures -461,928, giving a free cash flow of -11.76M billion.

Operating Cash Flow
-11.29M
Free Cash Flow
-11.76M
Free Cash Flow per Share
-0.79

Dividends & Yields

Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-132.87%
Earnings Yield
-124.94%

Stock Price Statistics

Beta
1.66
52-Week Price Change
-68.60%
50-Day Moving Average
0.73
200-Day Moving Average
1.51
Relative Strength Index (RSI)
43.69
Average Volume (3m)
287.17K

Important Dates

Daré Bioscience upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

Daré Bioscience as a current ratio of 1.14, with Debt / Equity ratio of 93.44%

Current Ratio
1.14
Quick Ratio
1.14
Debt to Market Cap
0.00
Net Debt to EBITDA
2.12
Interest Coverage Ratio
-16.47

Taxes

In the past 12 months, Daré Bioscience has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Daré Bioscience EV to EBITDA ratio is -0.35, with an EV/FCF ratio of -0.25.

EV to Sales
2.19
EV to EBITDA
-0.35
EV to Free Cash Flow
-0.25
EV to Operating Cash Flow
-0.27

Balance Sheet

Daré Bioscience has $12.62M in cash and marketable securities with $6.76M in debt, giving a net cash position of $5.85M billion.

Cash & Marketable Securities
$12.62M
Total Debt
$6.76M
Net Cash
$5.85M
Net Cash Per Share
$0.30
Tangible Book Value Per Share
-$0.04

Margins

Gross margin is -89.45%, with operating margin of -813.38%, and net profit margin of -804.37%.

Gross Margin
-89.45%
Operating Margin
-813.38%
Pretax Margin
-804.37%
Net Profit Margin
-804.37%
EBITDA Margin
-630.71%
EBIT Margin
-787.60%

Analyst Forecast

The average price target for Daré Bioscience is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$7.00
Price Target Upside
1098.63% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
―
EPS Growth Forecast
―

Scores

Smart Score
―
AI Score
43